Abstract
Chronic lymphocytic leukemia (CLL) is heterogeneous with respect to prognosis and clinical outcome. Mutational status of immunoglobulin heavy chain variable region (IGHV) appears to be a particularly strong prognostic marker, but it is difficult to perform in a routine clinical laboratory. ζ-chain-associated protein kinase 70 kDa (ZAP-70) protein detected by flow cytometry is a strong surrogate marker of IGHV mutational status; however, it suffers from the lack of standardization. We investigated whether ZAP-70 mRNA expression level can be a prognostic factor in CLL. Real-time quantitative polymerase chain reaction was used to analyze ZAP-70 mRNA expression from 102 CLL patients. The expression of ZAP-70 mRNA was significantly associated with Binet stage (P < 0.001), lactate dehydrogenase (P = 0.003), ZAP-70 protein (P = 0.018), IGHV mutational status (P = 0.038), and cytogenetic abnormality of del(17p13) or del(11q22.3) (P = 0.037) in CLL patients. According to receiver operating characteristic curve analysis for ZAP-70 mRNA and ZAP-70 protein, positive ZAP-70 mRNA (P = 0.006) was an adverse factor in determining the treatment free survival (TFS). In a multivariate Cox analysis of TFS, ZAP-70 mRNA is not ideal as an independen...Continue Reading
References
Jul 1, 1981·Cancer·J L BinetF Gremy
Dec 26, 2001·The Journal of Experimental Medicine·A RosenwaldL M Staudt
Jul 11, 2002·Annals of Hematology·T Hamblin
May 2, 2003·The New England Journal of Medicine·Marta CrespoEmili Montserrat
Jan 17, 2004·Lancet·Jenny A OrchardDavid G Oscier
Aug 27, 2004·The New England Journal of Medicine·Laura Z RassentiThomas J Kipps
Jul 29, 2005·Clinical and Laboratory Haematology·G GibbsS Johnson
Aug 20, 2005·Medical Oncology·Gerard Tobin, Richard Rosenquist
Mar 8, 2006·European Journal of Haematology·Mark A CatherwoodH Denis Alexander
Aug 15, 2006·Cytometry. Part B, Clinical Cytometry·O G BestD G Oscier
Aug 15, 2006·Cytometry. Part B, Clinical Cytometry·T Vincent ShankeyMike Keeney
Aug 15, 2006·Cytometry. Part B, Clinical Cytometry·M R SheikholeslamiM Albitar
Nov 4, 2006·Leukemia·R ZanottiM Chilosi
Aug 19, 2007·Clinical Chemistry·Basile StamatopoulosLaurence Lagneaux
Aug 5, 2008·Leukemia Research·Wei XuHong-Xia Qiu
Oct 25, 2008·Leukemia & Lymphoma·Hong-Xia QiuJian-Yong Li
Jul 25, 2009·International Journal of Hematology·Wei XuJian-Yong Li
Jun 22, 2011·Clinical and Experimental Medicine·Yin-Hua WangJian-Yong Li
Jun 28, 2011·Leukemia & Lymphoma·Darko AnticIvo Elezovic
Citations
Oct 9, 2012·Leukemia & Lymphoma·Yin-Hua WangWei Xu
Sep 13, 2013·ISRN Oncology·Piotr SmolewskiAnna Korycka-Wołowiec
Mar 14, 2014·Revista brasileira de hematologia e hemoterapia·Katarina HolandaMarcos Andre Bezerra
Oct 27, 2016·Leukemia Research·Ming HongJian-Yong Li
Sep 14, 2012·Hematology·V VroblovaJ Krejsek